Gene · 6876
Papers4,032
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 4,032
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis. | Hepatol Commun | 2022 | 35726350 | PubTator, text mining | PubMed |
| Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer. | Nat Genet | 2022 | 35726067 | PubTator, text mining | PubMed |
| Single Cell Transcriptomic Analysis Reveals Organ Specific Pericyte Markers and Identities. | Front Cardiovasc Med | 2022 | 35722109 | PubTator, text mining | PubMed |
| A combined human gastruloid model of cardiogenesis and neurogenesis. | iScience | 2022 | 35721464 | PubTator, text mining | PubMed |
| Models and Techniques to Study Aortic Valve Calcification in Vitro, ex Vivo and in Vivo. An Overview. | Front Pharmacol | 2022 | 35721220 | PubTator, text mining | PubMed |
| Present and Future Perspective on PLK1 Inhibition in Cancer Treatment. | Front Oncol | 2022 | 35719948 | PubTator, text mining | PubMed |
| Nintedanib regulates intestinal smooth muscle hyperplasia and phenotype in vitro and in TNBS colitis in vivo. | Sci Rep | 2022 | 35715562 | PubTator, text mining | PubMed |
| Sprouty-related proteins with EVH1 domain (SPRED2) prevents high-glucose induced endothelial-mesenchymal transition and endothelial injury by suppressing MAPK activation. | Bioengineered | 2022 | 35707829 | PubTator, text mining | PubMed |
| Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma. | Nat Commun | 2022 | 35697697 | PubTator, text mining | PubMed |
| Adipose-derived stromal cells increase the formation of collagens through paracrine and juxtacrine mechanisms in a fibroblast co-culture model utilizing macromolecular crowding. | Stem Cell Res Ther | 2022 | 35690799 | PubTator, text mining | PubMed |
| Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. | Toxicol Appl Pharmacol | 2022 | 35688186 | PubTator, text mining | PubMed |
| Variations in Blood Platelet Proteome and Transcriptome Revealed Altered Expression of Transgelin-2 in Acute Coronary Syndrome Patients. | Int J Mol Sci | 2022 | 35683019 | PubTator, text mining | PubMed |
| The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease. | Cells | 2022 | 35681530 | PubTator, text mining | PubMed |
| R-SPONDIN2+ mesenchymal cells form the bud tip progenitor niche during human lung development. | Dev Cell | 2022 | 35679862 | PubTator, text mining | PubMed |
| A systematic review of translation and experimental studies on internal anal sphincter for fecal incontinence. | Ann Coloproctol | 2022 | 35678021 | PubTator, text mining | PubMed |
| Cellular Crosstalk in the Vascular Wall Microenvironment: The Role of Exosomes in Vascular Calcification. | Front Cardiovasc Med | 2022 | 35677687 | PubTator, text mining | PubMed |
| Mammalian Sirtuins and Their Relevance in Vascular Calcification. | Front Pharmacol | 2022 | 35677446 | PubTator, text mining | PubMed |
| Insights from Transcriptomics: CD163+ Profibrotic Lung Macrophages in COVID-19. | Am J Respir Cell Mol Biol | 2022 | 35675555 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian Cancer. | Clin Cancer Res | 2022 | 35675036 | PubTator, text mining | PubMed |
| Exposure of intestinal explants to NX, but not to DON, enriches the secretome in mitochondrial proteins. | Arch Toxicol | 2022 | 35674809 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6876/papers?page=56